Effects of probucol on vascular remodeling after coronary angioplasty

Circulation

Volumn 99, Issue 1, 1999, Pages 30-35

  Côté, Gilles ^a   Tardif, Jean Claude ^a   Lespérance, Jacques ^a   Lambert, Jean ^a   Bourassa, Martial ^a   Bonan, Raoul ^a   Gosselin, Gilbert ^a   Joyal, Michel ^a   Tanguay, Jean François ^a   Nattel, Stanley ^a   Gallo, Richard ^a   Crépeau, Jacques ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Angioplasty; Antioxidants; Coronary disease; Remodeling; Restenosis; Ultrasonics

Indexed keywords

ANTIOXIDANT; MULTIVITAMIN; PLACEBO; PROBUCOL;

AGED; ANGIOGRAPHY; ARTICLE; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; DRUG EFFECT; FEMALE; HEART VENTRICLE REMODELING; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; VISCOELASTICITY;

EID: 0033547823     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.1.30     Document Type: Article

References (28)

1. Kakuta T, Currier JW, Haudenschild CC, Ryan TJ, Faxon DP. Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation. 1994;89:2809-2815.
2. Post MJ, Borst C, Kuntz RE. The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty: a study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation. 1994;89:2816-2821.
3. Gertz SD, Gimple LW, Banai S, Ragosta M, Powers ER, Roberts WC, Perez LS, Sarembock IJ. Geometric remodeling is not the principal pathogenetic process in restenosis after balloon angioplasty: evidence from correlative angiographic-histomorphometric studies of atherosclerotic arteries in rabbits. Circulation. 1994;90:3001-3008.
4. Lafont A, Guzman LA, Whitlow PL, Goormastic M, Comhill JF, Chisolm GM. Restenosis after experimental angioplasty: intimal, medial, and adventitial changes associated with constrictive remodeling. Circ Res. 1995;76:996-1002.
5. Gallo R, Gertz SD, Fallon JT, Chesebro JH, Fuster V, Badimon JJ. Fibromuscular hyperplasia and thrombosis are the predominant mechanisms for late luminal narrowing after balloon angioplasty in porcine coronary arteries. J Am Coll Cardiol. 1996;27:289A. Abstract.
6. DiMario C, Gil R, Camenzind E, Ozaki Y, von Birgelen C, Umans V, deJaegere P, deFeyter PJ, Roelandt JRTC, Serruys PW. Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy. Am J Cardiol. 1995;75:772-777.
7. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong C, Hong MK, Kovach JA, Leon MB. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation. 1996;94: 35-43.
8. Kimura T, Kaburagi S, Tamura T, Yokoi H, Nakagawa Y, Yokoi H, Hamasaki N, Nosaka H, Nobuyoshi M, Mintz GS, Popma JJ, Leon MB. Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy. Circulation. 1997;96:475-483.
9. Lee YJ, Daida H, Yokoi H, Miyano H, Takaya J, Sakurai H, Mokuno H, Yamaguchi H. Effectiveness of probucol in preventing restenosis after percutaneous transluminal coronary angioplasty. Jpn Heart J. 1996;37: 327-332.
10. Watanabe K, Sekiya M, Ikeda S, Miyagawa M, Hashida K. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty. Am Heart J. 1996;132:23-29.
11. Yokoi H, Daida H, Kuwabara Y, Nishikawa H, Takatsu F, Tomihara H. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial. J Am Coll Cardiol. 1997;30:855-862.
12. Tardif JC, Côté G, Lespérance J, Bourassa MG, Lambert J, Doucet S, Bilodeau L, Nattel S, deGuise P, for the MultiVitamins and Probucol Study Group. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med. 1997;337:365-372.
13. Mintz GS, Pichard AD, Popma JJ, Kent KM, Satler LF, Bucher TA, Leon MB. Determinants and correlates of target lesion calcium in coronary artery disease: a clinical, angiographic and intravascular ultrasound study. J Am Coll Cardiol. 1997;29:268-274.
14. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
15. Nunes GL, Sgoutas DS, Redden RA, Sigman SR, Gravanis MB, King SB, Berk BC. Combination of vitamins C and E alters the response to coronary balloon injury in the pig. Arterioscler Thromb Vase Biol. 1995; 15:156-165.
16. Schneider JE, Berk BC, Gravanis MB, Santoian EC, Cipolla GD, Tarazona N, Lassegue B, King SB. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury: a possible role for antioxidants in restenosis. Circulation. 1993;88:628-637.
17. Ferns GAA, Forster L, Stewart-Lee A, Konneh M, Nourooz-Zadeh J, Anggard EE. Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit. Proc Natl Acad Sci U S A. 1992;89:11312-11316.
18. Steinberg D. Studies on the mechanism of action of probucol. Am J Cardiol. 1986;57:16H-21H.
19. Kuzuya M, Naito M, Funaki C, Hayashi T, Asai K, Kuzuya F. Probucol prevents oxidative injury to endothelial cells. J Lipid Res. 1991;32: 197-204.
20. Parthasarathy S, Young SG, Witzum JL, Pittman RC, Steinberg D. Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest. 1986;77:641-644.
21. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZG. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. J Clin Invest. 1996;98:2572-2579.
22. Ku G, Doherty NS, Wolos JA, Jackson RL, Schmidt LF, Hendricks D. Inhibition by probucol of interleukin 1 secretion and its implication in atherosclerosis. Am J Cardiol. 1988;62:77B-81B.
23. Galis ZS, Muszynski M, Sukhova G, Simon-Morissey E, Unemori EN, Lark MW, Amento E, Libby P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res. 1994;75:181-189.
24. McLean LR, Thomas CE, Weintraub B, Hagaman KA. Modulation of the physical state of cellular cholesteryl esters by 4,4′-(isopropylidenedithio) bis (2,6-di-t-butylphenol) (probucol). J Biol Chem. 1992;267: 12291-12298.
25. Bowry V, Ingold KU, Stocker R. Vitamin E in human low-density lipoprotein: when and how this antioxidant becomes a pro-oxidant. Biochem J. 1992;288:314-344.
26. Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witzum JL. Effect of dietary antioxidant combinations in humans: protection of LDL by vitamin E but not by β-carotene. Arterioscler Thromb. 1993;13:590-600.
27. Lafont AM, Chai YC, Cornhill JF, Whitlow PL, Howe PH, Chisolm GM. Effect of alpha-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis. J Clin Invest. 1995;95:1018-1025.
28. Konneh MK, Rutherford C, Li SR, Anggard EE, Ferns GAA. Vitamin E inhibits the intimal response to balloon catheter injury in the carotid artery of the cholesterol-fed rat. Atherosclerosis. 1995;113:29-39.